Are FLT3 inhibitors likely to improve FLT3-mutated acute myeloid leukemia in the foreseeable future?

Sabine Kayser, Mark J Levis

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)123-126
Number of pages4
JournalInternational Journal of Hematologic Oncology
Issue number4
StatePublished - Dec 1 2016


  • AML
  • FTL3 mutations
  • genetics
  • leukemia
  • novel therapy

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Pharmacology (medical)

Cite this